Skyhawk Collaborate with Aragen to Develop Novel Small Molecule Therapeutics to Correct RNA Expression

 Skyhawk Collaborate with Aragen to Develop Novel Small Molecule Therapeutics to Correct RNA Expression

Skyhawk Collaborate with Aragen to Develop Novel Small Molecule Therapeutics to Correct RNA Expression

Shots:

  • Skyhawk collaborated with Aragen for the development of small molecule therapeutics that correct RNA expression
  • Under the collaboration, Skyhawk will get multiple discovery chemistry and biology service solutions from Aragen
  • The alliance focuses to accelerate Skyhawk’s research pipeline. Aragen’s research expertise will help Skyhawk to advance the development of its novel small molecule therapeutics targeting intractable diseases

Click here to read the full press release/ article | Ref: Aragen | Image: Aragen

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post